Rights and permissions
About this article
Cite this article
Premarketing drug trials are limited and excipients should be considered when ADRs are reported. React. Wkly. 339, 2–3 (1991). https://doi.org/10.2165/00128415-199103390-00005
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128415-199103390-00005